CIK 0001661053
- Non-accelerated filer
- Smaller reporting company
enVVeno Medical Corp
Sign in to watch- Ticker
- NVNO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330936180
- Phone
- +1 949-261-2900
- Business address
- 70 DOPPLER, IRVINE, CA, 92618
- Former names
- Hancock Jaffe Laboratories, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $123
- in 1 filing, $123 under 10b5-1 plans
Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | BERMAN ROBERT ANDREW Chief Executive Officer | Other disposition · Restricted Stock Units | −200,000 | 0 | ||
| 2024-12-19 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +12,000 | $2.55 | $31K | 222,236 |
| 2024-12-18 | BERMAN ROBERT ANDREW Chief Executive Officer | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2023-12-05 | BERMAN ROBERT ANDREW Chief Executive Officer | Grant or award · Stock Options | +300,000 | 300,000 | ||
| 2022-06-27 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +2,500 | $3.80 | $10K | 210,236 |
| 2021-11-30 | BERMAN ROBERT ANDREW Chief Executive Officer | Grant or award | +200,000 | 207,736 | ||
| 2021-11-30 | BERMAN ROBERT ANDREW Chief Executive Officer | Grant or award · Stock Options | +349,781 | 349,781 | ||
| 2021-11-19 | BERMAN ROBERT ANDREW CEO | Purchase | +2,000 | $7.43 | $15K | 7,736 |
| 2021-11-16 | BERMAN ROBERT ANDREW CEO | Purchase | +2,000 | $7.87 | $16K | 5,736 |
| 2021-05-18 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +3,000 | $5.47 | $16K | 3,736 |
| 2021-02-18 | BERMAN ROBERT ANDREW Chief Executive Officer | Grant or award · Stock Option | +838,000 | 838,000 | ||
| 2020-07-18 | BERMAN ROBERT ANDREW CEO | Other disposition · Stock Option | −1,080,207 | 0 | ||
| 2020-07-18 | BERMAN ROBERT ANDREW CEO | Grant or award · Stock Option | +1,080,207 | 1,080,207 | ||
| 2020-07-18 | BERMAN ROBERT ANDREW CEO | Grant or award · Stock Option | +1,000,000 | 1,000,000 | ||
| 2019-03-12 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +18,382 | $1.36 | $25K | 18,382 |
| 2019-03-12 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +21,740 | $1.15 | $25K | 21,740 |
| 2018-09-24 | BERMAN ROBERT ANDREW Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,080,207 | $2.71 | $2.9M | 1,080,207 |
Page 1 of 1 · 17 trades